This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Canoo (GOEV) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Canoo (GOEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
GOEVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Progressive (PGR) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Progressive (PGR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PGRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Visa (V) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Visa (V) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Grab (GRAB) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Grab (GRAB). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
GRABNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See SYMBOTIC INC (SYM) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for SYMBOTIC INC (SYM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SYMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Sea Limited (SE): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Sea Limited (SE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Silicon Motion (SIMO) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Silicon Motion (SIMO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SIMONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Nice (NICE): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nice (NICE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NICENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Alibaba (BABA): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Alibaba (BABA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BABAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Shopify (SHOP) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Shopify (SHOP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SHOPNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think SM Energy (SM) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for SM Energy (SM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Broadwind Energy (BWEN) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Broadwind Energy (BWEN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BWENNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Deckers (DECK) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Deckers (DECK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
DECKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Adobe (ADBE) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Adobe (ADBE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ADBENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Accenture (ACN) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ACNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Workday (WDAY): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Workday (WDAY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WDAYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Lithium Americas Corp. (LAC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Lithium Americas Corp. (LAC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LACNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think SkyWest (SKYW) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for SkyWest (SKYW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SKYWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Comcast (CMCSA) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Comcast (CMCSA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CMCSANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in P&G (PG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
PGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in ON Semiconductor Corp. (ON): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for ON Semiconductor Corp. (ON) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ONNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Monday.com (MNDY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Monday.com (MNDY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MNDYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
THCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ABBVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth